Evidence map›Paper›PMID 39518920›Full record

ArticleInternational journal of molecular sciences2024

Adunctin E from

Iksen Iksen, Natsaranyatron Singharajkomron, Hien Minh Nguyen, Hanh Nhu Thi Hoang, Duc Viet Ho, Varisa Pongrakhananon

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Iksen IksenDepartment of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0003-0166-4792
Natsaranyatron SingharajkomronDepartment of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
Hien Minh NguyenFaculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City 700000, Vietnam.
Hanh Nhu Thi HoangFaculty of Engineering and Food Technology, Hue University of Agriculture and Forestry, Hue University, Hue City 49000, Vietnam.
Duc Viet HoFaculty of Pharmacy, Hue University of Medicine and Pharmacy, Hue University, Hue City 49000, Vietnam.ORCID 0000-0002-7442-3925
Varisa PongrakhananonDepartment of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-2220-0842

Funding

Hue University DHH2023-04-197Thailand Science research and Innovation Fund, Chulalongkorn University HEAF67330003The Postdoctoral Scholarship Programme of Vingroup Innovation Foundation VINIF.2023.STS.30 to H.N.T.H.The Second Century Fund, Chulalongkorn University C2F to I.I.
6 · The paper itself

Abstract

Lung cancer stands out as a leading cause of death among various cancer types, highlighting the urgent need for effective anticancer drugs and the discovery of new compounds with potent therapeutic properties. Natural sources, such as the

Indexed as

ApoptosisHSP90 Heat-Shock ProteinsLung NeoplasmsMolecular Docking SimulationNetwork PharmacologyA549 CellsAntineoplastic AgentsCell Line, TumorChalconesHumansSignal TransductionAntineoplastic AgentsChalconesHSP90 Heat-Shock Proteinsadunctin EapoptosisConamomum rubidumlung cancermolecular dockingnetwork pharmacology

Identifiers

PMID39518920
PMCPMC11546842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.